Dr. Jody Berry joins Aspira from OraSure Technologies Inc., where he served as Chief Science Officer responsible for all innovation and product development including the breakthrough discovery of the first integrated swab test for COVID-19. Prior to that, Dr. Berry led immunochemistry research and development for Grifols Diagnostic Solutions, where he was responsible for the design of molecular and tissue culture laboratories and facilities for protein engineering, the development of a companion diagnostic for solid carcinomas using designer novel immune checkpoint inhibitor molecules and immunoassays for blood borne pathogens. He has also served in senior scientific and executive leadership roles for BD Biosciences and Cangene Corporation. Prior to beginning of his prestigious corporate career, he served as Head of Monoclonal Antibody and Bioforensics Response at the National Microbiology Laboratory of the Public Health Agency of Canada.
Dr. Berry has served as visiting or adjunct professor at Lehigh University, University of Western Michigan, and University of Manitoba. He is the recipient of numerous awards, including the Knudsen Memorial Publication Award from the American Biological Safety Association, the Government of Canada Public Service Commendation Award for post 9/11, CIHR HIV/AIDS Postdoctoral Fellowships, and the Apotex Fermentation Inc. Research Award for Doctoral Research in Molecular Biology. Dr. Berry is author or co- author on over 100 peer-reviewed published journal articles, abstracts, scientific posters, and monographs. Dr. Berry earned his Bachelor of Science with honors from the Department of Microbiology, and his Doctor of Philosophy from the University of Manitoba, Department of Medical Microbiology. His immunobiology studies on Chlamydia trachomatis, the leading cause of pelvic inflammatory disease and involuntary infertility in women, helped to outline protective host responses and to understand type immunity. He completed his post-doctoral fellowship at The Scripps Research Institute, Department of Molecular Biology where he was the first to create immune antibody libraries to HIV from cervical B cells collected from HIV-1 exposed, but uninfected subjects in Kenya.